Search PubMed⌕ Search

Biomedical subjects

C S Marcus

Publications and source records attributed to C S Marcus.

61 records · Page 4Linked to original sources
PubMedDate not supplied

Effects of AS-3 nutrient-additive solution on 42 and 49 days of storage of red cells.

Storage of red blood cells in a nutrient-additive solution, AS-3 (Nutricel, Cutter Biological, Berkeley, CA), was evaluated after 42 and 49 days of storage by in vitro measurements of hemolysis, adenosine triphosphate (ATP) levels, glucose levels and other constituents, and in vivo study of 24-hour survival of autologous, reinfused red cells labeled with 51Cr with and without 125I human serum albumin. Two laboratories conducted the studies independently. After 42 days of storage, hemolysis was within an acceptable range (0.72 +/- 0.4% and 1 +/- 0.2%), ATP decreased to 61 percent and 56 percent in the two laboratories, and 24-hour survivals were 85.1 +/- 8.3 percent for single-label cells in one laboratory and 82.8 +/- 10 percent (single-label cells) and 84.1 +/- 13.1 percent (double-label cells) in the second laboratory. Thus, results for single- and double-label cells were similar. After 49 days of storage, ATP fell to 45 and 46 percent in the two laboratories. Twenty-four-hour recovery fell to 69.4 +/- 7.4 percent with single-label cells and to 68.2 +/- 6.7 percent with double-label cells in one laboratory. In the other laboratory, a paired study comparing AS-3 with the already approved AS-1 solution (Adsol; Fenwal Laboratories, Deerfield, IL) showed nearly identical 24-hour survivals of 71.9 +/- 8.8 percent in Nutricel and 71.8 +/- 6.5 percent in Adsol. These studies demonstrate the excellent viability of the new solution after 42 days of study. At 49 days of study, viability decreased significantly and was comparable in the two nutrient-additive solutions studied. The value of paired comparison study is demonstrated by the latter results.

Blood Preservation↗
PubMedDate not supplied

Radiolabeled red cell viability. I. Comparison of 51Cr, 99mTc, and 111In for measuring the viability of autologous stored red cells.

The simultaneous determination of autologous 99mTc red cell (RBC) and 51Cr RBC viability at 24 hours was measured in 19 normal volunteers whose RBCs had been stored in additive media (Nutracel) for 42 or 49 days. The ratio of the 51Cr:99mTc value was 1.23. In this experiment we also calculated 51Cr RBC viability by both the single-isotope method (extrapolation) and the double-isotope method (using 125I human serum albumin for an independent plasma volume) in the same volunteers. The corresponding viability values were not significantly different. The simultaneous determination of autologous 111In-oxine RBC and 51Cr RBC viability at 24 hours was measured in 19 other normal volunteers whose RBCs had been stored in citrate-phosphate-dextrose-adenine (CPDA-1) for 1 or 15 days. The ratio of the 51Cr:111In value was 1.1. Use of these 24-hour viability ratios as conversion factors permits direct comparison of 99mTc or 111In RBC viability with a 51Cr standard, and therefore expands the application of these newer RBC radiolabels.

Blood Preservation↗
PubMedDate not supplied

Radiolabeled red cell viability. II. 99mTc and 111In for measuring the viability of heterologous red cells in vivo.

The authors developed a double in vivo crossmatch method using 2 to 3 ml of potential donor blood labeled with either 400 microCi of 99mTc or 30 microCi of 111In-oxine. Data are presented for 19 crossmatches on nine patients, using one blood specimen labeled with 99mTc or two specimens, one labeled with 99mTc and the other with 111In. Normal values are given for standardization purposes. This method appears to have advantages over earlier in vivo crossmatch techniques using 51Cr-labeled RBCs. These advantages include the rapidity with which the in vivo crossmatch may be repeated, the ready availability of 99mTc and 111In-oxine, and the lower radiation absorbed doses with the shorter-lived radionuclides.

Cell Survival↗
PubMedDate not supplied

Five-week red cell storage with preservation of 2,3 DPG.

The 2,3 diphosphoglycerate (2,3 DPG) content of red cells stored in current anticoagulant-preservative products decreases rapidly after the first few days of storage, and by 3 weeks the red cells are essentially depleted of 2,3 DPG. Because ascorbic acid and ascorbate-2-phosphate (A-2-P) are effective in maintaining erythrocyte 2,3 DPG during liquid preservation, ascorbate was stabilized through autoclaving and subsequent storage by adding it as the trisodium salt of A-2-P to a phosphate-adenine-saline solution at a pH of 8.5 to 9.0. Red cell concentrates prepared from blood drawn into citrate-phosphate-double-dextrose were supplemented with the A-2-P additive solution (AS-4) and studied in vitro and in vivo. Mean 2,3 DPG values for 22 units were 147.6, 113.5, and 82.3 percent of initial value after storage for 3, 4, and 5 weeks, respectively. Maintenance of 2,3 DPG was at the expense of adenosine triphosphate (ATP), which fell to as low as 22.2 percent of initial value after 5 weeks. Despite the low ATP values, the 24 hour 51Cr-labeled red cell recoveries averaged 80.8 and 74.1 percent after 4 and 5 weeks of storage, respectively. The AS-4 system provides a red cell product with acceptable viability and improved oxygen off-loading function.

2,3-Diphosphoglycerate↗
PubMedDate not supplied

The prediction of autologous red cell survival.

Nine donors predicted from earlier studies to have increased autologous red cell survival and four predicted to have lesser survival were selected from a pool of previously studied donors. Blood was drawn from these donors, and stored in Neutracel (R-Cutter Lab) preservative for eight hours at room temperature. The platelet rich plasma was removed, the additive solution was introduced, and the red cells were stored for 42 days in an approved refrigerator. At the end of the storage period, a 24 hour Cr-51 viability analysis was performed on each donor. Predicted red cell survival scores correlated reasonably well with the observed percent of red cell viability (r = 0.648). This study suggests that it may be possible to predict increased viability of autologous red cells in certain donors.

Blood Donors↗